NCT06693882Enrolling by invitation
Electrical Stimulation of the Optic Nerve in Patients With Glaucoma.
Electrical Stimulation of the Optic Nerve in Patients With Glaucoma : Prospective Analysis of Perimetric Data up to 12 Months After Neuromodulatory Treatment.
Source: ClinicalTrials.gov · Last updated 20 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this observational study is to evaluate electrical stimulation of the optic nerve with the Eyetronic Nextwave System device as a possible treatment for glaucoma. The main question it aims to answer is: Could this therapy be an option to counteract the loss of visual field seen in glaucoma and thus delay the progression of the disease? Participants will have approximately 14-18 study visits during 12 months including 10 visits for the electrical stimulation treatment. The treatment involves electrically stimulating the optic nerve by an external approach via the facial skin.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 15 Nov 2024
- Start date
- 1 Jan 2025
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Glaucoma Center of San Francisco
- Diseases
- Glaucoma
- NCT number
- NCT06693882
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 1 Jan 2025 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- IOP lowering medication started less than six months before enrollment
- Any intraocular surgery less than 6 months before enrollment
Other illness
- Epilepsy
- Arterial hypertension without appropriate treatment
- Acute retinal hemorrhage
Age
- Age \< 18 years
Other
- Implanted electronic devices
- Metallic artifacts in the head (except dentures)
- Migraine
- Brain tumor
- Pregnancy
- Breastfeeding patients
- Uncontrolled intraocular pressure (IOP)
Who the study is looking for
- Subjects 18 years or older who have glaucoma
- Humphrey visual field mean deviation (MD) values between - 6 dB and -20 dB
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Glaucoma Center of San Francisco Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.